On August 15, 2025, Bluejay Diagnostics, Inc. announced new leadership changes: Donald R. Chase as Board Chair, Douglas C. Wurth as Chair of the Nominating Committee, and Fred S. Zeidman as Chair of the Compensation Committee, with all being deemed independent by the Board.